Medications for the secondary prevention of ischaemic heart disease and heart failure are underutilized in dialysis patients

$48.00 plus tax (Refund Policy)

Download / Buy Article:

Abstract:

Abstract

We determined the prescription rates of medications for the secondary prevention of ischaemic heart disease and left ventricular systolic dysfunction in stable dialysis patients. In patients with established ischaemic heart disease, statins, beta-blockers and renin–angiotensin–aldosterone system blockers were substantially underprescribed. Furthermore, beta-blockers and renin–angiotensin–aldosterone system blockers were prescribed in less than half of those with left ventricular systolic dysfunction. Contraindications to treatment were infrequent and did not explain these findings.

Keywords: dialysis; ischaemic heart disease; left ventricular systolic dysfunction; secondary prevention

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1445-5994.2008.01649.x

Affiliations: 1: Departments of Cardiology 2: Nephrology, Wellington Hospital, Wellington, New Zealand

Publication date: May 1, 2008

Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more